Friend murine leukemia virus (Fr-MuLV) is a replication-competent murine retrovirus that induces acute nonlymphocytic leukemias in NFS/n mice. Fr-MuLV disease is divided into two stages based on the ability of the leukemia cells to grow in culture and transplant into syngeneic mice. Hematopoietic cells taken from the early stage of disease after Fr-MuLV infection grow as immortal myeloid cell lines in the presence of WEHI-3 cell-conditioned medium (CM) or interleukin 3. These growth factor-dependent cell lines do not grow in culture in the absence of CM and do not form tumors in syngeneic animals. If these Fr-MuLV-infected cells are superinfected with Abelson murine leukemia virus (Ab-MuLV), they lose their dependence on WEHI-3 CM and proliferate in culture in the absence of exogenous growth factors. Concomitant with the loss of growth factor dependence in culture, the Ab-MuLV-infected cell lines become tumorigenic in syngeneic mice. This secondary level of transformation is Ab-MuLV specific. Fr-MuLV-immortalized myeloid cell lines superinfected with Harvey murine sarcoma virus (Ha-MuSV) or amphotropic virus remain dependent on WEHI-3 CM for growth in vitro and are not tumorigenic in vivo. Neither Ab-MuLV-nor HaMuSV-infected normal mouse myeloid cell cultures produce growth factor-independent or tumorigenic cell lines. We conclude that at least two genetic events are needed to convert a murine myeloid precursor into a tumorigenic cell line. The first event occurs in Fr-MuLV-infected mice, generating cells that are growth factor dependent but immortal in vitro. The second event, which can be accomplished by Ab-MuLV infection, converts these immortal myeloid precursors into growth factor-independent and tumorigenic cells. 
. The specific genetic events responsible for stage I and stage II transformation of hematopoietic precursors are unknown.
Hematopoietic cells obtained from mice with stage I leukemia will grow as immortal cell lines if cultured in the presence of WEHI-3 cell-conditioned medium (CM) or interleukin 3 (IL-3) (5). These cell lines are not identical to the FrMuLV-infected leukemia cells found in mice. Fr-MuLV disease in vivo manifests as an erythroleukemia. CM-dependent cell lines grown in vitro consist of myeloblasts and other elements of the myeloid cell lineage. However, these CMdependent myeloid cells exhibit growth properties similar to the stage I erythroleukemia cells of mice. CM-dependent cell lines do not form tumors in syngeneic mice, and they do not grow in culture in the absence of CM. After >18 months in culture, these cells remain absolutely dependent on CM for proliferation. In an attempt to alter the growth factor requirements of the CM-dependent cell lines, we superinfected these cells with two acutely transforming retroviruses Abelson murine leukemia virus (Ab-MuLV) and Harvey murine sarcoma virus (Ha-MuSV).
METHODS
Animals. NFS/n mice were originally obtained from the small animal facility of the National Institutes of Health (Bethesda, MD). Subsequently, mice were bred by brother/sister matings in our own laboratory.
Cells. NIH 3T3 cells were obtained from the American Type Culture Collection. WEHI-3 cells were a gift from Edward Scolnick of Merck Sharp & Dohme. Conditioned medium from WEHI-3 cells was obtained 5 days after passaging WEHI-3 cells in Dulbecco's modified Eagle's medium (DME medium) with 10% fetal calf serum. WEHI-3 cells were removed by centrifugation (1000 x g for 10 min), and the clarified supernatant was frozen at -20'C until needed. All CM-dependent cell lines were grown in DME medium with 10% fetal calf serum and 10% WEHI-3 CM. Bone marrow cultures were established in 60-mm Petri dishes by flushing the contents of two femurs into 5 ml of CM-dependent cell line medium. These cultures were demi-depopulated every 3-4 days and fed with an equal volume of fresh media.
Viruses. Fr-MuLV is a replication-competent, NB-tropic, ecotropic, type C retrovirus obtained by transfection of molecularly cloned Fr-MuLV DNA into NIH 3T3 cells (2) . Amphotropic virus (designated "Ampho") is a replication-competent, N-tropic, amphotropic, type C retrovirus obtained by the transfection of molecularly cloned Ampho DNA into NIH 3T3 cells (6 (10) . To overcome this problem, we prepared pseudotypes of Ab-MuLV and Ha-MuSV, using an amphotropic murine retrovirus-Ampho (11) . I03 and Elc cells were removed from culture, washed, and resuspended in fresh medium with CM and 104 ffu of Ab-MuLV/Ampho or Ha-MuSV/Ampho or 105 infectious units of Ampho virus. After 1 week in culture with CM, the Ab-MuLV/Amphoand Ha-MuSV/Ampho-infected cells were assayed for growth in the absence of CM. Suspension cultures of 103 and Elc cells superinfected with Ab-MuLV/Ampho continued to grow to high cell density (1-2 x 106 cells per ml) in the absence of CM. These cells also produced dense colonies of 103 and Elc cells in soft agar without CM. However, the IO3 and Elc cells superinfected with Ha-MuSV/Ampho or Ampho alone did not grow in the absence of CM in suspension cultures or in soft agar (Table 1) .
To prove that the Ab-MuLV/Ampho and Ha-MuSV/Ampho viruses had infected the 103 and Elc cells, the culture 4 , designated cl-1 and cl-4) were picked and expanded in suspension culture. High molecular weight DNA and poly(A)+ RNA was isolated from cl-1 and cl-4 cells and probed for the presence of AbMuLV sequences. Southern blot analysis revealed multiple Ab-MuLV bands in cl-1 and cl-4 that were not present in the parental I03 cells (Fig. 1) . Similarly, RNA blot analysis revealed high levels of Ab-MuLV-specific transcripts in cl-1 and cl-4 cells (Fig. 2) . Parallel filters hybridized with a murine leukemia virus long terminal repeat and gag probe recognized the same RNA species as did the abl probe (data not shown). These studies indicate that Ab-MuLV is present and is actively transcribed in cl-1 and cl-4.
Since I03 and Elc cells are dependent on IL-3 for growth in culture, we asked if the growth factor-independent derivatives of I03 and Elc make their own IL-3. Southern blot analysis of the IL-3 gene locus in cl-1, cl-4, and I03 showed the same pattern of bands comprising the IL-3 coding sequences in all three cell lines (Fig. 3) . RNA dot-blot analysis of poly(A)+ RNA from cl-1, c1-4, and I03 revealed the same abundance of IL-3-specific sequences in the growth factordependent and -independent cell lines (Fig. 4) . These experiments indicate that the IL-3 gene is not rearranged or expressed at elevated levels in Ab-MuLV/Ampho-infected factor-independent cells. To further test the possibility that these cell lines produce a self-stimulating growth factor, CM was prepared from cl-1 and c1-4 cells and tested for the ability to stimulate proliferation of two IL-3-dependent cell lines-103 and FD (12) . To test the tumorigenic potential of the growth factor-independent cell lines, 1 6, and 9 ). Electrophoresis and blot-transfer were performed as in Fig. 1 . Hybridization was performed by using a radiolabeled nick-translated molecularly cloned IL-3 cDNA. Filter washings were carried out as described in Fig. 1 (Table 2) . However, no CM-independent cell lines were established from these cultures, and no tumor cell foci developed in the spleens of mice injected with these cells.
103 and Elc are myeloid cell lines. The myeloid nature of these cells was established by histochemical staining and (Table 2) . Fr-MuLV is more likely needed to activate an endogenous cellular oncogene via insertional mutagenesis (19, 20) . This type of Fr-MuLV-induced mutation is likely to be a rare genetic event and may not occur during the limited life span of normal myeloid cell cultures (3-6 weeks). However, in vivo many more myeloid precursors are exposed to Fr-MuLV infection, thus increasing the likelihood that Fr-MuLV will integrate near a critical gene in at least one myeloid precursor.
Several investigators have shown that at least two oncogenes are needed to transform primary mouse embryo fibroblasts into tumorigenic cells (21) (22) (23) . One gene provides so called "immortalizing" functions. The second gene is then capable of inducing malignant cell transformation, but only in the presence of the immortalizing gene. One or more of these "immortalization" oncogenes may be activated in 103 and Elc cells.
Ab-MuLV and Ha-MuSV transform both fibroblasts and hematopoietic cells in vitro and in vivo (24) (25) (26) (27) (28) (29) (30) (31) . Little is known about the mechanism of cell transformation used by these viruses. We have found that Ab-MuLV but not HaMuSV converts IL-3-dependent myeloid cell lines into growth factor-independent cells. Concomitant with the loss of growth factor dependence, the Ab-MuLV-infected cells become tumorigenic in syngeneic animals. This study suggests that the cellular basis of Ab-MuLV-induced myeloid cell transformation is elimination of the requirement for growth factors for cell division. Ha-MuSV-induced hematopoietic cell transformation must be accomplished by a different mechanism since Ha-MuSV-infected cell lines remain dependent on WEHI-3 CM for cell proliferation. The molecular basis of Ab-MuLV-induced IL-3 independence is unclear. However, analysis of cl-1 and c1-4 cells fails to support the "autocrine" model of tumorigenesis (32) . CM obtained from these cells does not support the growth of hematopoietic factor-dependent cell lines. No evidence of altered IL-3 transcription or rearranged IL-3 DNA sequences is found in cl-i or cl-4. Instead of triggering the production of IL-3, AbMuLV appears to make IL-3 superfluous for cell proliferation.
